| Period Ending | Mar 30, 2012 | Mar 30, 2011 | Mar 30, 2010 |
|---|
|
Total Revenue
|
126,375
|
101,151
|
85,713
| | Cost of Revenue | 24,507 | 21,977 | 22,529 | | |
Gross Profit
|
101,868
|
79,174
|
63,184
| |
|
Operating Expenses |
|
Research Development | 27,159 | 26,677 | 25,954 |
|
Selling General and Administrative | 71,711 | 62,287 | 60,837 |
|
Non Recurring |
-
|
-
|
-
|
|
Others | 1,478 | 1,395 | 1,469 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
| | | |
Operating Income or Loss
|
1,520
|
(11,185)
|
(25,076)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 1,023 | 322 | 6,723 |
|
Earnings Before Interest And Taxes | 2,543 | (10,863) | (18,353) |
|
Interest Expense |
-
|
-
|
-
|
|
Income Before Tax | 2,543 | (10,863) | (18,353) |
|
Income Tax Expense | 1,048 | 892 | 671 |
|
Minority Interest |
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 1,495 | (11,755) | (19,024) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
| | | |
Net Income
|
1,495
|
(11,755)
|
(19,024)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
1,495
|
(11,755)
|
(19,024)
|
|